Skip to main content
. 2018 Jan 20;36(4):467–475. doi: 10.1007/s40273-018-0610-0

Table 2.

Summary of preferred specification: rejection vs. non-rejection (full/conditional approval) (n = 91)

Variable (reference level) Coefficient Standard error p value Marginal effects (%) Change in LL
Intercept 1.1361 0.5808 0.05
Quality of clinical evidence (high) − 1.6961 0.6083 0.005 − 26.0 − 4.39
Rel. survival × AE (low) − 0.6174 0.3762 0.10 − 9.47 − 1.53
Limited treatments (yes) × AE (low) − 1.3095 0.9845 0.18 − 20.1 − 1.45

AE adverse event, LL Log likelihood